Order NO. D225020
兔抗TP63多克隆抗體
英文名 | Anti-TP63 rabbit polyclonal antibody | ||
別名 | tumor protein p63; AIS; KET; LMS; NBP; RHS; p40; p51; p63; EEC3; OFC8; p73H; p73L; SHFM4; TP53L; TP73L; p53CP; TP53CP; B(p51A); B(p5 | ||
相關類別 | 一抗 | 儲存 | 冷凍(-20℃) |
宿主 | Rabbit | 反應種屬 | Human, Mouse, Rat |
標記物 | Unconjugate | 克隆類型 | rabbit polyclonal |
抗原 | TP63 | ||
編 號 | 包裝 | 庫存 | 目錄價(¥) | 您的價格(¥) | 數 量 |
D225020-0025 | 25 ul | 現貨 |
|
||
D225020-0100 | 100 ul | 現貨 |
|
||
D225020-0200 | 200 ul | 現貨 |
|
技術規格
Background: | This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. |
Applications: | ELISA, WB, IHC |
Name of antibody: | TP63 |
Immunogen: | Fusion protein of human TP63 |
Full name: | tumor protein p63 |
Synonyms: | AIS; KET; LMS; NBP; RHS; p40; p51; p63; EEC3; OFC8; p73H; p73L; SHFM4; TP53L; TP73L; p53CP; TP53CP; B(p51A); B(p51B) |
SwissProt: | Q9H3D4 |
ELISA Recommended dilution: | 5000-10000 |
IHC positive control: | Human lung cancer |
IHC Recommend dilution: | 50-200 |
WB Predicted band size: | 77 kDa |
WB Positive control: | PC3 and Jurkat cell lysates |
WB Recommended dilution: | 500-2000 |